323 related articles for article (PubMed ID: 16212)
1. Enzyme replacement therapy of exocrine pancreatic insufficiency in man. Relations between in vitro enzyme activities and in vivo potency in commercial pancreatic extracts.
Graham DY
N Engl J Med; 1977 Jun; 296(23):1314-7. PubMed ID: 16212
[TBL] [Abstract][Full Text] [Related]
2. Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules.
DiMagno EP; Malagelada JR; Go VL; Moertel CG
N Engl J Med; 1977 Jun; 296(23):1318-22. PubMed ID: 16213
[TBL] [Abstract][Full Text] [Related]
3. Medical treatment of pancreatic insufficiency.
DiMagno EP
Mayo Clin Proc; 1979 Jul; 54(7):435-42. PubMed ID: 36518
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
Dutta SK; Rubin J; Harvey J
Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
[TBL] [Abstract][Full Text] [Related]
5. In vitro comparative study of three pancreatic enzyme preparations: dissolution profiles, active enzyme release and acid stability.
Aloulou A; Puccinelli D; Sarles J; Laugier R; Leblond Y; Carrière F
Aliment Pharmacol Ther; 2008 Feb; 27(3):283-92. PubMed ID: 17973644
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro enzyme activities of five commercially available pancreatic supplements.
Shaw DW; Barbezat GO
N Z Med J; 1982 Jun; 95(710):424-5. PubMed ID: 6180364
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency.
Regan PT; Malagelada JR; DiMagno EP; Glanzman SL; Go VL
N Engl J Med; 1977 Oct; 297(16):854-8. PubMed ID: 20572
[TBL] [Abstract][Full Text] [Related]
8. Effects of product formulation on in vitro activity of pancreatic enzymes.
Dressman JB; Shtohryn LV; Diokno D
Am J Hosp Pharm; 1985 Nov; 42(11):2502-6. PubMed ID: 4073069
[TBL] [Abstract][Full Text] [Related]
9. [Therapy of pancreatogenic steatorrhea. Comparison of 2 acid-protected enzyme preparations].
Lankisch PG; Lembcke B; Kirchhoff S; Hilgers R; Creutzfeldt W
Dtsch Med Wochenschr; 1988 Jan; 113(1):15-7. PubMed ID: 3335192
[TBL] [Abstract][Full Text] [Related]
10. Management of chronic pancreatitis. Focus on enzyme replacement therapy.
Dobrilla G
Int J Pancreatol; 1989; 5 Suppl():17-29. PubMed ID: 2702247
[TBL] [Abstract][Full Text] [Related]
11. Fate of orally ingested enzymes in pancreatic insufficiency: comparison of two pancreatic enzyme preparations.
Delchier JC; Vidon N; Saint-Marc Girardin MF; Soule JC; Moulin C; Huchet B; Zylberberg P
Aliment Pharmacol Ther; 1991 Aug; 5(4):365-78. PubMed ID: 1777547
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of a new microencapsulated pancreatin versus a conventional preparation, in the treatment of steatorrhea of pancreatic origin].
Aparisi L; Rodrigo JM; Serra MA; Del Olmo J; Bisquert M; Raga F
Rev Esp Enferm Apar Dig; 1989 Jul; 76(1):25-30. PubMed ID: 2799034
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic enzyme replacement therapy. Importance of gastric acid secretion, H2-antagonists, and enteric coating.
Marotta F; O'Keefe SJ; Marks IN; Girdwood A; Young G
Dig Dis Sci; 1989 Mar; 34(3):456-61. PubMed ID: 2563963
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic enzyme replacement therapy: comparative effects of conventional and enteric-coated microspheric pancreatin and acid-stable fungal enzyme preparations on steatorrhoea in chronic pancreatitis.
Schneider MU; Knoll-Ruzicka ML; Domschke S; Heptner G; Domschke W
Hepatogastroenterology; 1985 Apr; 32(2):97-102. PubMed ID: 2408983
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic steatorrhea: action of a total lyophilized pancreas preparation: an "in vitro" and "in vivo" study.
Dani R; Ribeiro TC; Penna FJ; Nogueira CE
Arq Gastroenterol; 1986; 23(3):152-8. PubMed ID: 3435264
[TBL] [Abstract][Full Text] [Related]
16. [Pancreatic enzymes--substitution preparations].
Berndt W
Z Allgemeinmed; 1972 Dec; 48(35):1641-4. PubMed ID: 4649287
[No Abstract] [Full Text] [Related]
17. [The in-vitro digestive availability of lipase and trypsin in pancreatic supplements under different degrees of acidity].
Sixtos Alonso MS; Morales LA; Galván E; Robles-Díaz G; Uscanga L; Campuzano M
Rev Gastroenterol Mex; 1993; 58(1):21-4. PubMed ID: 8362147
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic enzyme replacement therapy in post-pancreatectomy patients.
Braga M; Cristallo M; De Franchis R; Mangiagalli A; Zerbi A; Agape D; Primignani M; Di Carlo V
Int J Pancreatol; 1989; 5 Suppl():37-44. PubMed ID: 2702249
[TBL] [Abstract][Full Text] [Related]
19. Proteolytic inactivation of lipase as a possible cause of the uneven results obtained with enzyme substitution in pancreatic insufficiency.
Pap A; Varró V
Hepatogastroenterology; 1984 Feb; 31(1):47-50. PubMed ID: 6199274
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
Delhaye M; Meuris S; Gohimont AC; Buedts K; Cremer M
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
